Competitive intelligence
Side-by-side comparison
Up to six companies on the same rows. Empty cells say what is missing rather than hiding it.
2 of 6 columns
Comparison
| Attribute | Obsidian Therapeutics, Inc.12.9remove | BirchBioMed Inc.14.3remove |
|---|---|---|
| Signal scores | ||
| Radar composite | 12.9 | 14.3 |
| IPO signal score | 25.8 | 28.6 |
| Tokenization signal score | 0.0 | 0.0 |
| On-chain readiness | 0.0 | 0.0 |
| Momentum | ACCELERATING+11.5 | ACCELERATING+15.0 |
| Company | ||
| Stage | filed | filed |
| Sector | not on record | not on record |
| Headquarters | CAMBRIDGE | KING CITY |
| Founded | not on record | not on record |
| Employees | not on record | not on record |
| Capital | ||
| Latest valuation | not on record | not on record |
| Total funding | not on record | $12M |
| Latest round | not on record | Private Placement $596K |
| Investors on record | 0 | 0 |
| Evidence | ||
| Institutional relationships | 0 | 0 |
| Active signals | 9 | 7 |
| Confidence | 72% | 80% |
IPO Radar is a research and intelligence tool. Scores are signal scores derived from public evidence — they are not calibrated probabilities and not investment advice. FACT, INFERENCE and PREDICTION are kept separate, and every event links to its source.